Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Motor Activity 9Breast Neoplasms 7Neoplasms 4Fatigue 3Recurrence 2Body Weight 2Weight Loss 1Warts 1Vomiting 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Neoplasm Metastasis 1Nausea 1Multiple Myeloma 1Lymphoma, Follicular 1Lymphoma 1Lung Neoplasms 1Leukemia 1Insulin Resistance 1Hodgkin Disease 1Hematologic Neoplasms 1Hematologic Diseases 1Head and Neck Neoplasms 1Dementia 1Colonic Neoplasms 1Cognitive Dysfunction 1Asthenia 1Anomia 1Alzheimer Disease 1

Interventions

Megestrol Acetate 2Exercise 2Resistance Training 1Metformin 1Diet Therapy 1Caseins 1Caloric Restriction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Body Weight × Exercise × Clear all
NCT01482286 2022-03-15

PULSE

Pennington Biomedical Research Center

Phase 3 Terminated
32 enrolled 10 charts

Body Weight, Insulin Resistance, Motor Activity, Polycystic Ovary Syndrome

NCT02107066 2018-04-20

WALC

Yale University

Phase 3 Completed
144 enrolled
Gynecologic

Body Weight, Fatigue, Motor Activity, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡